Non-specific Response to H1N1 Vaccine

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2010 by The University Clinic of Pulmonary and Allergic Diseases Golnik.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
The University Clinic of Pulmonary and Allergic Diseases Golnik
ClinicalTrials.gov Identifier:
NCT01178918
First received: August 4, 2010
Last updated: August 9, 2010
Last verified: August 2010

August 4, 2010
August 9, 2010
November 2009
Not Provided
  • T Cell Immune responce monitoring after Influenza A (H1N1) AS03-Adjuvanted Vaccination [ Time Frame: At 3 weeks after vaccination ] [ Designated as safety issue: Yes ]
  • T Cell Immune responce monitoring after Influenza A (H1N1) AS03-Adjuvanted Vaccination [ Time Frame: At 11 weeks after vaccination. ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT01178918 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Non-specific Response to H1N1 Vaccine
Enhanced Non-Specific T Lymphocytes Response to Influenza A (H1N1) AS03-Adjuvanted Vaccine

This is a prospective observational study with recruitment of healthy volunteers from consecutive recipients of H1N1 influenza vaccine at the University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia.

The purpose of this study is to evaluate certain safety aspects of adjuvanted influenza H1N1 vaccines.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Healthy volunteers from consecutive recipients of H1N1 influenza vaccine at the University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia.

Influenza H1N1
Not Provided
Healthy volunteers from recipients of H1N1 vaccine
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
15
Not Provided
Not Provided

Inclusion Criteria:

  • Recipients of H1N1 influenza vaccine.
  • Healthy individuals with no signs of influenza or other infectious disease.

Exclusion Criteria:

  • Signs of influenza or other infectious disease in 1 month before study participation.
Both
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
Slovenia
 
NCT01178918
KOPA-H1N1-01
No
Head of PMO, The University Clinic of Pulmonary and Allergic Diseases Golnik
The University Clinic of Pulmonary and Allergic Diseases Golnik
Not Provided
Not Provided
The University Clinic of Pulmonary and Allergic Diseases Golnik
August 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP